Related Experiment Videos
Serum immunoglobulins in brain tumours
Acta Neurochirurgica
|January 1, 1992
Summary
This study found elevated immunoglobulin (Ig) levels in patients with brain tumors. Specifically, IgM and IgG increased in all tumor types, while IgA was high only in benign cases, suggesting prognostic value.
Area of Science:
- Neuroimmunology
- Oncology
- Clinical Chemistry
Background:
- Intracranial space-occupying lesions (ISOLs) encompass a range of conditions, including brain tumors.
- Immunoglobulins (Igs) play a crucial role in the immune response and their levels can be altered in various pathological conditions.
- Understanding changes in serum immunoglobulin levels in ISOLs may offer insights into disease mechanisms and patient outcomes.
Purpose of the Study:
- To investigate and quantify serum immunoglobulin levels (IgM, IgG, IgA) in patients with intracranial space-occupying lesions.
- To compare immunoglobulin levels between patients with different types of brain tumors and healthy controls.
- To explore the potential prognostic significance of altered serum immunoglobulin levels in intracranial space-occupying lesions.
Main Methods:
- Sera from 62 patients with intracranial space-occupying lesions were analyzed.
- Radial immunodiffusion method was employed for the quantitative assay of serum immunoglobulins.
- Serum samples were compared against control groups.
Main Results:
- A highly significant increase in serum IgM levels was observed across all types of brain tumors compared to controls.
- Serum IgG levels were elevated in both benign and malignant intracranial space-occupying lesions.
- Elevated serum IgA levels were specifically noted in benign cases only.
Conclusions:
- Increased serum IgM and IgG levels are characteristic of brain tumors, regardless of malignancy.
- Elevated serum IgA may be indicative of benign intracranial space-occupying lesions.
- Serum immunoglobulin levels show potential as prognostic biomarkers for intracranial space-occupying lesions.